ACCESS THYROGLOBULIN 33860

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-12-31 for ACCESS THYROGLOBULIN 33860 manufactured by Chaska Discrete Mfg Io.

Event Text Entries

[131723790] The customer did not provide patient demographics such as date of birth, weight, ethnicity or race. The access thyroglobulin reagent was not returned for evaluation. All assay and system verifications met specifications at the time of this incident. No hardware errors, flags or other assay issues were reported in conjunction with this event. One patient sample was sent to the beckman coulter complaint handling unit (chu) for investigation. Patient sample was first tested neat after centrifugation for the access thyroglobulin assay. The chu obtained a high access thyroglobulin result. Customer's results were therefore confirmed. An interference testing, using different blockers, was then carried out. The blockers used in the interference testing are animal derived antibodies. Scavenger alp, a blocker related to alkaline phosphatase, was also tested. Interference antibodies interaction are listed in the limitations section of the access thyroglobulin instructions for use. This interference testing demonstrated the presence of interfering substances since animal derived antibodies used in the test significantly lowered the signal. The cause of this event is a patient source interferent.
Patient Sequence No: 1, Text Type: N, H10


[131723791] On (b)(6) 2018 the customer reported that reproducible elevated thyroglobulin (access thyroglobulin) results had been generated on the customer's unicel dxi 800 access immunoassay system (serial number (b)(4)) for one patient. The elevated access thyroglobulin results were released from the laboratory. The patient's samples were analyzed utilizing other methodologies and recovered with negative results. Actual results were not provided. There was a report of change to patient care or treatment which occurred in connection with this event. The patient underwent mri (magnetic resonance imaging). There was no report of further injury or change to patient management reported in this event. Calibration, quality control and system check were all performing within specifications at the time of the incident. Information regarding patient sample collection and processing was not provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2122870-2018-01037
MDR Report Key8206504
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-12-31
Date of Report2018-12-31
Date of Event2018-11-30
Date Facility Aware2018-12-03
Date Mfgr Received2018-12-03
Device Manufacturer Date2017-10-12
Date Added to Maude2018-12-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. DAVID DAVIS
Manufacturer Street250 S. KRAEMER BLVD.
Manufacturer CityBREA CA 928218000
Manufacturer CountryUS
Manufacturer Postal928218000
Manufacturer Phone7149613796
Manufacturer G1BECKMAN COULTER
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACCESS THYROGLOBULIN
Generic NameACCESS THYROGLOBULIN REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Product CodeMSW
Date Received2018-12-31
Model Number33860
Catalog Number33860
Lot Number724117
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerCHASKA DISCRETE MFG IO
Manufacturer Address1000 LAKE HAZELTINE DRIVE CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-12-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.